Here is a thorough overview of community-based management of pneumonia in Nepal, drawing on the sources gathered:
Community-Based Management of Pneumonia in Nepal
Background and Epidemiological Context
Pneumonia remains one of the leading causes of under-five mortality in Nepal. The country's mountainous terrain, geographic inaccessibility, poor road networks, and shortage of health facility staff historically made facility-only referral strategies inadequate - children in remote hill and mountain districts could not realistically be taken to a health post quickly enough. These barriers drove Nepal to become a global pioneer in delegating pneumonia treatment to community-level workers.
Nepal has reduced under-five mortality by more than 50% since 1990, and community-based pneumonia management has been recognized as a central contributor to achieving its Millennium Development Goal 4 target.
Evolution of the Program
1. ARI Program (1987) - Facility-Based Origin
Nepal's Acute Respiratory Infection (ARI) Program started in 1987 as a purely facility-based initiative. During the mid-1990s, recognition grew that referral was not always feasible because of geographic inaccessibility, prompting a shift toward community-level care.
2. Pilot Study in Jumla and Four Districts (Mid-1990s)
A critical pilot in Jumla district tested whether community health workers (CHWs) - specifically Village Health Workers (VHWs), Maternal Child Health Workers (MCHWs), and Female Community Health Volunteers (FCHVs) - could safely classify and treat pneumonia. Two districts followed a treatment model (diagnosis and oral cotrimoxazole at community level) and two a referral-only model. The treatment model proved more effective with negligible antibiotic overuse. A formal WHO/UNICEF/USAID evaluation in 1997 confirmed FCHVs' ability to deliver quality pneumonia assessment and management. Community-based management doubled the total number of cases treated compared to facility-only districts.
3. CB-IMCI Rollout (1997-2009)
Community-Based Integrated Management of Childhood Illness (CB-IMCI) was formally launched in 1997 and scaled to all 75 districts by 2009. It integrated pneumonia and diarrhea case management with the existing FCHV cadre. By that time, 69% of Nepal's under-five population had access to pneumonia treatment through this program.
4. CB-IMNCI (2014 onwards)
In 2014, Nepal merged CB-IMCI and the Community-Based Newborn Care Package (CB-NCP) into a single CB-IMNCI (Community-Based Integrated Management of Neonatal and Childhood Illness) program. This coincided with the adoption of the revised 2014 WHO IMCI protocol. An important policy shift was made: the role of FCHVs was limited to promotive and preventive health services (counseling, referral, health education), with curative antibiotic prescribing shifted to trained health workers at health posts and sub-health posts.
The FCHV Cadre
FCHVs are the backbone of Nepal's community health system. Key features:
- Selection: Local women chosen by their communities
- Motivation: Non-financial - increased social status and community recognition. Many had personally lost children to pneumonia, making them highly motivated.
- Compensation: Standard government allowance only for training and review meetings; no regular salary
- Scale: Over 26,000 FCHVs and VHW/MCHWs were trained in CB-IMCI
- Literacy challenge: A large proportion of FCHVs were illiterate when the program began. Pictorial tools (color-coded respiratory rate timers, flip charts) were developed to overcome this.
- Trust: The established, accepted nature of FCHVs in communities was a critical success factor - communities already recognized and trusted them.
Clinical Classification of Pneumonia (CB-IMCI / CB-IMNCI)
The traffic-light (Red/Yellow/Green) color-coded system used in Nepal:
| Classification | Signs | Action |
|---|
| Red - Severe Pneumonia / Very Severe Disease | General danger signs: unable to feed/suck, vomits everything, convulsions, lethargy or unconsciousness; plus chest indrawing, stridor | Urgent referral to health facility; pre-referral amoxicillin/benzylpenicillin |
| Yellow - Pneumonia | Fast breathing (≥50 breaths/min in 2-12 months; ≥40/min in 1-5 years); no general danger signs | Oral antibiotics + home care advice + follow-up |
| Green - Cough and Cold | No fast breathing, no chest indrawing | Home care advice only |
Fast breathing thresholds (age-based):
- 2-12 months: ≥50 breaths per minute
- 1-5 years: ≥40 breaths per minute
Respiratory rate counting uses a 1-minute timer (originally a mechanical ARI timer; now automated counting devices are being trialed in Nepal).
Treatment Protocol
Original CB-IMCI (before 2014 WHO revision)
- Non-severe pneumonia (fast breathing): Cotrimoxazole-Pediatric (Cotrim-P) tablets, oral, 5-day course
- FCHVs provided this antibiotic at community level
- Severe pneumonia: Refer urgently; pre-referral benzylpenicillin at sub-health post
Revised Protocol (2014 WHO guideline, adapted in Nepal)
Following the 2014 WHO revision, oral amoxicillin replaced cotrimoxazole as the first-line treatment for non-severe pneumonia:
- Fast breathing pneumonia AND chest-indrawing pneumonia (without danger signs) are now both classified as "pneumonia" and treated with oral amoxicillin dispersible tablets (DT), 5 days
- Amoxicillin dosing by age/weight:
- 2-12 months (4-<10 kg): 250 mg twice daily
- 12 months - 3 years (10-<14 kg): 500 mg twice daily
- 3-5 years (14-19 kg): 500 mg twice daily (or 1000 mg once daily)
- Severe pneumonia (any general danger sign, oxygen saturation <90%): Referral + injectable ampicillin/gentamicin or benzylpenicillin at hospital
Under CB-IMNCI, antibiotic prescribing for "Yellow" cases is now primarily done by Health Assistants and Auxiliary Health Workers at sub-health posts and health posts, while FCHVs focus on case identification and referral.
Key Program Components
- Training: Short intensive training (5-day Phase 1 + 2-day Phase 2) covering ARI/pneumonia assessment, diarrhea management, nutrition, and immunization
- Respiratory rate counting: Using a 1-minute timer; automated devices trialed for accuracy (PMID: 31762072)
- Drug supply: Cotrim-P (previously) and amoxicillin DT maintained at community level
- Follow-up: Cases reassessed on day 3 - deterioration or non-improvement triggers referral
- Referral system: Severe and very severe cases referred urgently; health facilities are the backstop
- Mothers' groups: Community orientation through mothers' group meetings
- Support and supervision: Periodic reviews, cold chain maintenance, resupply of drugs
Program Achievements
- Community-based management doubled pneumonia case detection and treatment compared to facility-only districts
- 69% of Nepal's under-five population had access to pneumonia treatment through community workers at program peak
- Case fatality rate for acute diarrhoea and proportion of severe pneumonia decreased significantly at national level
- Nepal achieved MDG 4 (50% reduction in under-5 mortality since 1990) - one of only five countries to do so
- Over 26,099 community health workers trained; 4,406 health workers trained
- Community members, traditional healers (6,308), and mothers' group members (352,628) oriented to support CB-IMCI
Challenges and Limitations
- Literacy: Many FCHVs were illiterate; required pictorial/color-coded job aids
- Geographic barriers: Severe weather and terrain still complicate referral and drug resupply
- Referral compliance: High non-compliance with referral advice remains a problem in LMICs generally
- Quality concerns: Assessment of CB-NCP in 2012 revealed quality of care issues with FCHWs/MCHWs for neonatal care, influencing the 2014 policy decision to limit FCHV curative roles
- Neonatal mortality: Progress in child mortality has been stronger than neonatal mortality; the SDG NMR target (<12/1000 live births) remains challenging
- Antibiotic stewardship: Transition from cotrimoxazole to amoxicillin needed re-training; monitoring antibiotic overuse remains ongoing
Nepal's Significance as a Global Model
Nepal's CB-pneumonia program has been cited by
WHO/UNICEF as a flagship example in the global iCCM evidence base. The WHO/UNICEF joint statement on iCCM notes Nepal's "more than 20 years of experience" and that community management of all childhood pneumonia cases could achieve up to 70% reduction in pneumonia mortality. Nepal's model - particularly delegating antibiotic treatment to illiterate volunteers - was initially controversial but has since informed programs in sub-Saharan Africa, South Asia, and other high-burden LMICs.
Key reference: Dawson P et al., "From Research to National Expansion: 20 Years' Experience of Community-Based Management of Childhood Pneumonia in Nepal,"
Bulletin of the World Health Organization, vol. 86, no. 5, 2008, pp. 339-343 (
PMC2647452).